We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 688

Actualidad Normativa N.º 8
  • Gómez-Acebo & Pombo Abogados
  • European Union, Spain
  • July 21 2014

En materia medioambiental consideramos de interés las siguientes normas: El Real Decreto 1632014, de 14 de marzo, por el que se crea el Registro de

The Issues 2014 - upcoming legal topics in the Czech Republic
  • CMS Cameron McKenna
  • Czech Republic, European Union
  • January 24 2014

Since the summer, M&A practitioners across Europe have been talking about their ‘cautiously optimistic’ forecast for the markets. The first two

Draft regulation on clinical trials - abolishment of obligatory insurance
  • Bird & Bird
  • European Union
  • February 25 2013

In July 2012 the European Commission published its proposal for a "Regulation on clinical trials on medicinal products for human use" (COM 2012 369

A summary of major developments in key areas - general counsel update - July 2014
  • Herbert Smith Freehills LLP
  • Australia, European Union, Hong Kong, United Kingdom
  • July 15 2014

Legislation, in the form of a Regulation and Directive, has been published in the Official Journal of the European Union which will substantially

Sidley Austin LLP global pricing newsletter - volume three 2014
  • Sidley Austin LLP
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare

Indemnity arrangements for healthcare professionals: long overdue
  • Kennedys Law LLP
  • European Union, United Kingdom
  • July 26 2013

The Department of Health's consultation on the implementation of the Health Care and Associated Professions (Indemnity Arrangements) Order 2013 (the

Johnson & JohnsonNovartis another challenge to pay for delay: is this ever permissible?
  • Bryan Cave LLP
  • European Union, France, Germany, Italy, United Kingdom
  • January 14 2014

In the latest challenge to so-called “pay for delay” or “reverse payment” agreements, on 10 December 2013, the European Commission fined the

BUPA loses Irish state aid appeal
  • Shepherd and Wedderburn LLP
  • European Union, Ireland
  • February 29 2008

On 12 February, the Court of First Instance (CFI) issued its judgment in Case T-28903, dismissing an application by BUPA to annul a decision of the European Commission (the Commission) in respect of a risk equalisation system for the private medical insurance sector in Ireland

CFI rejects BUPA’s complaint of Ireland’s risk equalisation system
  • Nabarro LLP
  • European Union, Ireland
  • February 27 2008

The Court of First Instance (CFI) has upheld the Commission’s decision to reject BUPA’s complaint that the Irish authorities’ risk equalisation system (RES) constitutes illegal state aid to the private medical insurance sector

European Court of Justice considers the validity of Flemish legislation limiting eligibility to a care insurance scheme
  • Locke Lord LLP
  • Belgium, European Union
  • April 10 2008

In Government of the French Community, and Walloon Government v Flemish Government Case C-21206, ECJ (Grand Chamber), the European Court of Justice (ECJ) determined that Flemish legislation limiting eligibility to a care insurance scheme was contrary to European provisions concerning the right to freedom of movement within the European Community (EC) in so far as the care insurance scheme included a residence requirement that excluded persons who worked in the Flemish region or in the bilingual Brussels-Capital, but who resided in another part of the national territory (ie the French or German speaking region